Results 121 to 130 of about 487 (151)
A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic
, 2020 Alimova M, Sidhom E, Satyam A, Dvela-Levitt M, Melanson M, Chamberlain BT, Alper SL, Santos J, Gutierrez J, Subramanian A, Grinkevich E, Bricio ER, Kim C, Clark A, Watts A, Thompson R, Marshall J, Pablo JL, Coraor J, Roignot J, Vernon KA, Keller K, Campbell A, Emani M, Racette M, Bazua-Valenti S, Padovano V, Weins A, McAdoo SP, Tam FW, Ronco L, Wagner F, Tsokos GC, Shaw JL, Greka A. +34 moreeuropepmc +1 more sourceRAAS blockade, kidney disease, and expression of ACE2 , the entry receptor for SARS-CoV-2, in kidney epithelial and endothelial cells
, 2020 Subramanian A, Vernon KA, Slyper M, Waldman J, Luecken MD, Gosik K, Dubinsky D, Cuoco MS, Keller K, Purnell J, Nguyen L, Dionne D, Rozenblatt-Rosen O, Weins A, Human Cell Atlas Lung Biological Network, Regev A, Greka A. +16 moreeuropepmc +1 more sourceThe chromatin landscape of healthy and injured cell types in the human kidney. [PDF]
Nat CommunGisch DL, Brennan M, Lake BB, Basta J, Keller MS, Melo Ferreira R, Akilesh S, Ghag R, Lu C, Cheng YH, Collins KS, Parikh SV, Rovin BH, Robbins L, Stout L, Conklin KY, Diep D, Zhang B, Knoten A, Barwinska D, Asghari M, Sabo AR, Ferkowicz MJ, Sutton TA, Kelly KJ, De Boer IH, Rosas SE, Kiryluk K, Hodgin JB, Alakwaa F, Winfree S, Jefferson N, Türkmen A, Gaut JP, Gehlenborg N, Phillips CL, El-Achkar TM, Dagher PC, Hato T, Zhang K, Himmelfarb J, Kretzler M, Mollah S, Kidney Precision Medicine Project (KPMP), Jain S, Rauchman M, Eadon MT. +46 moreeuropepmc +1 more source
